DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ rose 3.26% to $9.50 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.34% to 26,021.66 and Dow Jones Industrial Average falling 0.98% to 51,492.55.
Novavax Inc. closed 20.63% below its 52-week high of $11.97, which the company reached on February 26th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.42% to $234.20, Pfizer Inc. $(PFE)$ fell 0.46% to $25.92, and Merck & Co. Inc. $(MRK)$ rose 0.23% to $115.44.
Trading volume (3.9 M) remained 839,242 below its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 17, 2026 17:27 ET (21:27 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments